Case Study: How a Baseline Map Helped Detect a Slow-Growing Melanoma

Mole Mapping Case Study: Baseline Map Saves Lives

This mole mapping case study illustrates how sequential digital dermoscopy imaging (SDDI) and a comprehensive baseline map enabled the early detection of a slow-growing melanoma. The case demonstrates that subtle, visually imperceptible changes in a mole’s pigment network can indicate malignancy, emphasizing the critical role of advanced, technology-assisted skin surveillance. A baseline map provides an objective reference point, allowing consultants to identify minute evolutions that would otherwise be missed by self-monitoring or standard visual checks. This approach significantly improves the chances of early skin cancer diagnosis.

London Skin Clinic provides consultant-led mole mapping services, utilizing advanced FotoFinder Digital Dermoscopy and AI-powered analysis. This expertise ensures precise, evidence-based skin surveillance for early and accurate melanoma detection, enhancing patient outcomes through meticulous clinical practice.

To explore your options, contact us to schedule your consultation. You can also reach us via: Schedule a Harley Street Mole Check

How a Baseline Map Uncovered a Slow-Growing Melanoma

A baseline map detected a slow-growing melanoma that appeared visually unchanged over 12 months. The high-resolution record from the initial appointment allowed consultants to make a direct digital comparison during the annual follow-up. This comparison revealed subtle structural changes in the mole’s pigment network, invisible to the naked eye but indicative of early malignant transformation.

This example highlights a limitation of self-monitoring. Many skin cancers evolve slowly, with subtle alterations in structure, symmetry, or colour detectable only with magnified, sequential imaging. The initial map is a definitive reference point, turning a subjective observation (“Does this look different?”) into an objective, data-driven analysis. Without this baseline, the lesion’s subtle evolution would likely have been missed, delaying diagnosis and leading to a poorer prognosis.

The Science of Early Detection: How SDDI Reveals Subtle Changes

Early skin cancer diagnosis relies on identifying changes at the earliest stage. Sequential Digital Dermoscopy Imaging (SDDI) makes this possible. A dermatoscope uses polarised light and high magnification to see beneath the skin’s surface, revealing structures, colours, and patterns invisible to the naked eye. SDDI captures and stores these high-resolution images, creating a digital record of each mole.

Creating Your Baseline Visual Record: The Importance of SDDI

Effective surveillance begins with a comprehensive baseline. An initial mole mapping appointment involves creating your baseline visual record using Sequential Digital Dermoscopy Imaging (SDDI). This includes systematic, high-resolution photography of the entire body to map every significant lesion. Individual moles of interest are then imaged with the digital dermatoscope.

This initial set of images is the definitive “map” of your skin. This record makes future comparisons accurate and objective. Each subsequent scan is digitally overlaid and compared against this baseline, allowing detection of the smallest changes.

FotoFinder AI: Enhancing Accuracy in Mole Surveillance

London Skin Clinic uses the FotoFinder system, which integrates artificial intelligence to enhance mole surveillance accuracy. The system’s AI assists in follow-ups by automatically comparing new images to the baseline, flagging new lesions or highlighting existing moles that have changed in size, shape, or structure.

This technology aids the consultant, ensuring no subtle change is missed across hundreds of moles. The AI provides a “second set of eyes,” drawing the expert’s attention to relevant areas for human analysis. Learn more about how FotoFinder AI technology improves mole surveillance and the process.

Patient Story: Tracking a Melanoma’s Subtle Evolution

A male in his late 50s with a history of significant sun exposure and multiple moles attended London Skin Clinic for proactive skin surveillance.

The Initial Baseline: A Foundation for Future Surveillance

On his first visit in early 2025, a baseline map was created using the FotoFinder system. Over 150 lesions were documented with total body photography, and 25 moles were selected for dermoscopic imaging. A 4mm mole on his upper back was noted as symmetric with a regular pigment network. It was deemed benign on initial consultant review but recorded for future comparison.

Detecting the Undetectable: Subtle Changes Over 12 Months

The patient returned for his annual review 12 months later, reporting no self-observed changes. Visually, the mole on his back appeared identical. However, when the new dermoscopic image was compared digitally to the baseline, the FotoFinder software flagged subtle changes. Consultant plastic surgeon Mr. Onur Gilleard’s expert review revealed a new, faint, asymmetric scattering of pigment at one edge and a slight disruption to the pigment network. These changes were invisible without direct, magnified comparison to the baseline image. Based on these structural shifts, an excision and biopsy were recommended. The histology report confirmed the lesion was a melanoma in situ—the earliest stage of melanoma.

Consultant-Led Mole Mapping: The Gold Standard for Early Melanoma Detection

AI is a tool, but it cannot replace the diagnostic skill of a medical expert. Final interpretation and diagnosis require a specialist. This case shows why consultant diagnosis is essential for reliable skin cancer screening. The AI flagged a change, but the consultant’s dermoscopy expertise was required to interpret the structural changes as malignant.

Beyond AI: The Indispensable Role of Expert Dermatoscopic Review

A GMC-registered consultant plastic surgeon or dermatologist has years of training in recognising skin lesion patterns. They can differentiate between benign changes (e.g., a mole growing symmetrically in an adolescent) and the signs of early malignancy. They assess the full clinical picture, including patient history and risk factors, which an algorithm cannot. This human oversight prevents missed diagnoses and unnecessary excisions of benign lesions.

Why Consultant Diagnosis Matters: Avoiding Misdiagnosis and Delayed Treatment

Relying on automated analysis or review by less qualified practitioners is risky. Misinterpretation can provide false reassurance, allowing a melanoma to progress. The NHS states that early detection is paramount for successful treatment. At London Skin Clinic, a consultant reviews every mole map to ensure diagnostic accuracy. This consultant-led approach is key to addressing the need for timely and accurate skin cancer treatment.

The Life-Saving Impact: What Early Melanoma Detection Means

This case illustrates how a baseline map saves lives. Because the melanoma was detected at the in situ stage (Stage 0), it was confined to the epidermis. It had not yet developed the ability to spread. Treatment was a simple surgical excision with clear margins, which is curative at this stage. The patient required no further treatment beyond regular follow-up surveillance.

Prognosis and Treatment: The Advantage of Early Intervention

Melanoma prognosis is tied to the diagnosis stage. Early detection is the most important factor for a positive outcome. As melanoma progresses and invades deeper into the skin (increasing its Breslow thickness), the risk of metastasis increases, and treatments become more aggressive, often involving lymph node biopsies, immunotherapy, or targeted therapy.

Statistics from bodies like Cancer Research UK demonstrate this advantage. The difference in survival rates between early and late-stage diagnosis is stark, reinforcing the importance of proactive skin surveillance.